Also trades as: AVE.AX (ASX) · $vol 0M
AVEFF OTC
Avecho Biotechnology Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -10.0%
5Y: -10.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1M
-4.4% ▼
5Y CAGR: +26.3%
Gross Profit
$751K
-9.9% ▼
5Y CAGR: +25.5%
Operating Income
-$6M
-25.1% ▼
Net Income
-$4M
-41.4% ▼
EPS (Diluted)
$0.00
+230.0% ▲
EBITDA
-$6M
-100.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $794K | $1M | $474K | $1M | $1M |
| YoY Growth | +106.3% | +52.0% | -60.7% | +173.3% | -4.4% |
| Cost of Revenue | $286K | $336K | $517K | $461K | $486K |
| Gross Profit | $508K | $870K | -$44K | $833K | $751K |
| Gross Margin | 64.0% | 72.1% | -9.2% | 64.4% | 60.7% |
| R&D Expenses | $2M | $2M | $1M | $0 | $4M |
| SG&A Expenses | $3M | $1M | $3M | $2M | $2M |
| Operating Expenses | $5M | $4M | $5M | $6M | $7M |
| Operating Income | -$5M | -$3M | -$5M | -$5M | -$6M |
| Operating Margin | -573.5% | -254.1% | -969.1% | -370.7% | -485.1% |
| Interest Expense | $10K | $6K | $15K | $57K | $461K |
| Income Before Tax | -$3M | -$2M | -$3M | -$3M | -$6M |
| Tax Expense | $0 | $0 | $0 | $0 | -$2M |
| Net Income | -$3M | -$2M | -$3M | -$3M | -$4M |
| Net Margin | -430.4% | -194.2% | -725.8% | -241.3% | -356.8% |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $0.00 |
| EBITDA | -$3M | -$2M | -$3M | -$3M | -$6M |
| Shares Outstanding | 1.80B | 1.84B | 2.27B | 3.17B | 3.27B |